Uterine Carcinosarcoma — Trials

Uterine Carcinosarcoma — Trials · CancerIndex

Clinical trials

Registered studies

34 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 8
Recruiting: 5
Ph III recruiting: 3
Growth YoY: —
Industry share: 13%
Top sponsor: ARCAGY/ GINECO GROUP
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (7)

clinicaltrialsPublishedShowing 1–3 of 3 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03120624	VSV-hIFNbeta-NIS With or Without Ruxolitinib Phosphate in Treating Stage IV or Recurrent Endometrial Cancer	active not recruiting	Phase 1	34	Mayo ClinicOTHER	1	Jul 21, 2026	clinicaltrials
NCT04106414	Study of BMS-986205 and Nivolumab in Endometrial Cancer or Endometrial Carcinosarcoma That Has Not Responded to Treatment	active not recruiting	Phase 2	24	Memorial Sloan Kettering Cancer CenterOTHER	1	Oct 14, 2025	clinicaltrials